ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients sought for new hope in Tough-to-Treat blood cancer
Disease control Not yet recruitingThis is the first study in people for a new drug called PF-07994525, developed by Pfizer. It aims to find a safe dose and see if the drug shows early signs of fighting cancer in adults with advanced multiple myeloma that has stopped responding to other treatments. The study will …
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Cancer drug safety test: will it mix with your meds?
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new cancer drug called pelabresib interacts with three common medications: a diabetes drug, a sedative, and a birth control pill. Researchers will enroll 24 adults with advanced cancers who have run out of standard treatment options…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC